Quanterix (QTRX) Free Cash Flow Growth (1y) (2018 - 2026)
Powered by 
Analysis
Quanterix (QTRX) Free Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.43 Bn | 221.37 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 144.26 Bn | 139.91 Bn | 3.61 Bn | 16.06% |
| 3 | Agilent Technologies | 40.88 Bn | 39.12 Bn | 1.04 Bn | 69.50% |
| 4 | Illumina | 30.92 Bn | 29.75 Bn | 770.00 Mn | -21.08% |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn | 56.67% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | -6.83% |
| 7 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | -5.79% |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | 27.54% |
| 9 | 10x Genomics | 8.74 Bn | 8.18 Bn | 112.50 Mn | -4.61% |
| 10 | Quanterix | 125.23 Mn | 31.70 Mn | 12.67 Mn | 18.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.92% |
| Mar 31, 2026 | -20.14% |
| Dec 31, 2025 | -246.75% |
| Sep 30, 2025 | -535.43% |
| Jun 30, 2025 | 1.80% |
| Mar 31, 2025 | 26.73% |
| Dec 31, 2024 | 42.19% |
| Sep 30, 2024 | -37.54% |
| Jun 30, 2024 | -2,911.16% |
| Mar 31, 2024 | -107.30% |
| Dec 31, 2023 | -43.45% |
| Sep 30, 2023 | 74.05% |
| Jun 30, 2023 | 101.80% |
| Mar 31, 2023 | 56.82% |
| Dec 31, 2022 | 54.59% |
| Sep 30, 2022 | -5.01% |
| Jun 30, 2022 | 23.76% |
| Mar 31, 2022 | -62.97% |
| Dec 31, 2021 | -535.71% |
| Sep 30, 2021 | -114.46% |